Back to Search Start Over

FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor.

Authors :
Bello IO
Alrabeeah MA
AlFouzan NF
Alabdulaali NA
Nieminen P
Source :
Clinical oral investigations [Clin Oral Investig] 2021 Mar; Vol. 25 (3), pp. 1559-1567. Date of Electronic Publication: 2020 Jul 17.
Publication Year :
2021

Abstract

Objective: Integrins function to bind cells to extracellular matrix in tissues, which triggers downstream signaling cascades that are important in cell survival, proliferation, cytokine activation, and cytoskeleton reorganization. These processes also play significant roles in neoplasms. This work aimed to investigate the pattern of expression of FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor (AOT).<br />Materials and Methods: Immunohistochemistry was used to study FAK, paxillin, and PI3K in 45 ameloblastomas (32 conventional, 12 unicystic, and 1 peripheral types), 7 AOTs, and two developing human teeth.<br />Results: Weak expression of FAK was seen in all AOT cases, while ameloblastoma had varying expression patterns, mostly strong to weak. The pattern of expression of paxillin and PI3K was relatively similar in both tumor types. In the dental germ, FAK and paxillin stained all the enamel organ components, while PI3K stained strongly the inner enamel epithelium. Stromal expression of FAK was not found to be useful in differentiating between tumors or tumor classes.<br />Conclusion: The expression of the proteins in the enamel organ suggests that their signaling may be important in odontogenesis. While some ameloblastomas strongly expressed FAK, all cases of AOT had weak signals suggesting low presence and phosphorylating activity of FAK in the latter.<br />Clinical Relevance: A subset of FAK-positive ameloblastoma (as well as their malignant or metastasizing counterparts) which may have relatively aggressive behavior may be candidates for drug targeting of FAK as an additional management option.

Details

Language :
English
ISSN :
1436-3771
Volume :
25
Issue :
3
Database :
MEDLINE
Journal :
Clinical oral investigations
Publication Type :
Academic Journal
Accession number :
32681423
Full Text :
https://doi.org/10.1007/s00784-020-03465-4